Estonia – Pharmaceutical products – Ravim Pertuzumab + trastuzumab L01XY01 subkutaanne süstelahus
sihtasutus Tartu Ülikooli Kliinikum awarded €4.0M to TAMRO EESTI OÜ for Healthcare & Medical in October 2025 — one of 1,374 awards this buyer has made, above its typical award size.
Buying agency
sihtasutus Tartu Ülikooli KliinikumWinning supplier
TAMRO EESTI OÜContract description
Estonia – Pharmaceutical products – Ravim Pertuzumab + trastuzumab L01XY01 subkutaanne süstelahus
Related awards · sihtasutus Tartu Ülikooli Kliinikum
1,374 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-25493-2025-1AS Alexela€40.0M14 Jan 2025 Energy
- ocds-ted-25493-2025-2Enefit AS€40.0M14 Jan 2025 Energy
- ocds-ted-673390-2024Illumina Netherlands BV€10.8M05 Nov 2024 Healthcare
Other wins · TAMRO EESTI OÜ
39 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-196031-2024-1sihtasutus Põhja-Eesti Regionaalhaigla€7.0M03 Apr 2024 Healthcare
- ocds-ted-105665-2025Aktsiaselts Ida-Tallinna Keskhaigla€2.4M17 Feb 2025 Healthcare
- ocds-ted-330279-2024Aktsiaselts Ida-Tallinna Keskhaigla€1.4M05 Jun 2024 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for sihtasutus Tartu Ülikooli Kliinikum and TAMRO EESTI OÜ — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back